ALC logo

ALCAlcon Inc. - Registered Shares

$66.85
$0.34
(0.51%)
Today
Closed $66.85
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
EarningsAug 10
Mkt Cap$32.58B
Vol1.22M
News
all
press releases
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
TNDM's pay-as-you-go shift, international expansion and strong liquidity support growth, while macro and reimbursement risks remain.
Zacks
News Placeholder
More News
News Placeholder
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's Surgical and Vision Care units returned to 6% growth in Q1 2026, but tariffs, macro pressure and fierce competition still loom.
Zacks
News Placeholder
Reasons to Retain STE Stock in Your Portfolio for Now
STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.
Zacks
News Placeholder
EYE Q1 Earnings & Revenues Beat Estimates, Operating Margin Expands
National Vision beats EPS and revenue estimates as comps rise 4.5% and operating margin jumps 320 bps; 2026 guidance reiterated.
Zacks
News Placeholder
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down
Prestige Consumer misses Q4 EPS and revenue estimates as Clear Eyes supply limits and Middle East shipping disruptions pressure sales and margins.
Zacks
News Placeholder
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.
Zacks
News Placeholder
HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut
Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets its FY27 growth outlook.
Zacks
News Placeholder
GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised
Globus Medical beats Q1 EPS estimates by 22% as revenues rise 27% to $759.9M; margins widen and 2026 EPS outlook up, lifting shares 5.8%.
Zacks
News Placeholder
Here's Why Alcon (ALC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion, up 10% on a...
Business Wire
<
1
2
...
>